Study | Reason For Exclusion |
---|---|
Unkila-Kallio 1993 | Mainly epidemiologic data. Appears to be the cohort from which Peltola 1997 is drawn. |
Dones 1994 | Small prospective cohort of 4 patients evaluating teicoplanin. |
Nelson 1982 | Study addressed bactericidal titers. Follow-up did not extend to 6 months although reported cure rate was 95% with an average duration of 5 days of intravenous antimicrobials. |
Beauvais 1981 | Addressed the use of pristinamycin orally. Data was not usable because group could not be reliably separated for route and type of antimicrobial. |
Fleming 1970 | No follow-up data available. Trial focussed on microbiology and side effects of treatment. |
Nussinovitch 1997 | Data on osteomyelitis cases alone could not be extracted. Maximum follow-up was about 4 months. Cure appeared to be 95% with mean duration of IV antibiotics of 13.7 days. |
Walker 1973 | Follow-up was 4 months. Mean duration of intravenous antimicrobials in 14 children was 4.21 days (range 2–21 days) and cure was 100%. |
Bandelon 1988 | Group of osteomyelitis and septic arthritis could not be separated with respect to length of therapy or etiology. |
Kulhanjianv 1989 | Only 3 cases of osteomyelitis due to S. aureus. |
Aronoff 1986 | Of 9 children only 1 child had osteomyelitis alone. No follow-up. |
Learmonth 1984 | Combined patients with septic arthritis and osteomyelitis. Could not extract data with respect to S. aureus alone. |